VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SEM
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
SEMSelect Medical Holdings Corporation
$16.54$2.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksSEMQuarterly Financials

Select Medical Holdings Corporation (SEM) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Select Medical Holdings Corporation (SEM) quarterly income statement — complete revenue, gross profit & net income history

SEM Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Sales/Revenue1.42B1.4B1.36B1.34B1.35B-122.59M1.76B1.28B1.79B1.22B1.67B1.67B
Revenue Growth %5.05%1239.3%-22.59%4.51%-24.35%-110.06%5.73%-23.46%7.44%-22.98%6.24%5.67%
Cost of Goods Sold1.25B1.29B1.22B1.18B1.17B36.91M1.52B1.12B1.49B1.11B1.44B1.42B
COGS % of Revenue87.66%92.15%89.19%88.4%86.66%-30.11%86.53%87.53%83.55%91.09%86.6%85.02%
Gross Profit175.47M109.63M147.45M155.45M180.56M-159.5M237.32M159.81M294.2M108.57M223.19M250.93M
Gross Margin %12.34%7.85%10.81%11.6%13.34%130.11%13.47%12.47%16.45%8.91%13.4%14.98%
Gross Profit Growth %-2.82%168.74%-37.87%-2.73%-38.63%-246.91%6.33%-36.31%19.51%-37.12%28.28%29.22%
Operating Expenses77.05M45.69M74.49M68.92M67.82M65.09M96.19M85.95M100.23M44.09M93.22M91.72M
OpEx % of Revenue5.42%3.27%5.46%5.14%5.01%-53.1%5.46%6.71%5.6%3.62%5.6%5.48%
Selling, General & Admin39.38M45.69M40.05M35.66M33.01M80.2M47.35M49.88M48.45M44.09M41.32M42.51M
SG&A % of Revenue2.77%3.27%2.94%2.66%2.44%-65.42%2.69%3.89%2.71%3.62%2.48%2.54%
Research & Development000000000000
R&D % of Revenue------------
Other Operating Expenses1000K01000K1000K1000K-1000K1000K1000K1000K01000K1000K
Operating Income98.42M63.94M72.96M86.53M112.75M-224.59M141.13M73.86M193.97M64.48M129.96M159.2M
Operating Margin %6.92%4.58%5.35%6.46%8.33%183.2%8.01%5.76%10.84%5.29%7.8%9.51%
Operating Income Growth %-12.71%128.47%-48.31%17.16%-41.87%-448.31%8.6%-53.61%28.07%-25.77%42.08%31.61%
EBITDA136.08M100.14M107.4M121.38M147.55M-178.84M191.28M127.8M248.04M99.96M182.35M209.14M
EBITDA Margin %9.57%7.17%7.88%9.06%10.9%145.89%10.86%9.97%13.87%8.21%10.95%12.49%
EBITDA Growth %-7.77%155.99%-43.85%-5.02%-40.51%-278.91%4.89%-38.9%21.66%-28.14%27.59%21.56%
D&A (Non-Cash Add-back)37.67M36.2M34.44M34.85M34.81M45.74M50.14M53.94M54.07M35.48M52.39M49.94M
EBIT079.08M85.85M100.15M125.26M-228.39M163.26M83.85M204.39M75.13M126.83M169.71M
Net Interest Income0-28.61M-29.92M-29.98M-29.07M14.7M-55.44M-37.11M-50.76M-50.8M-50.27M-49M
Interest Income000000000000
Interest Expense-28.34M28.61M29.92M29.98M29.07M-14.7M55.44M37.11M50.76M50.8M50.27M49M
Other Income/Expense-16.32M-13.47M-17.03M-16.36M-16.56M10.9M-33.31M-18M-40.34M-29.61M-53.4M-38.5M
Pretax Income82.09M50.46M55.93M70.17M96.19M-213.69M107.82M55.85M153.63M34.87M76.56M120.71M
Pretax Margin %5.78%3.61%4.1%5.24%7.11%174.32%6.12%4.36%8.59%2.86%4.6%7.21%
Income Tax18.32M12.72M11.75M12.29M21.45M-50.73M26.81M18.21M36.46M4.62M15.74M28.85M
Effective Tax Rate %22.31%25.21%21.01%17.52%22.3%23.74%24.86%32.61%23.73%13.24%20.56%23.9%
Net Income43.99M20.17M28.79M40.57M56.68M-16.05M55.63M77.56M96.9M46.27M48.18M78.24M
Net Margin %3.09%1.44%2.11%3.03%4.19%13.09%3.16%6.05%5.42%3.8%2.89%4.67%
Net Income Growth %-22.38%225.69%-48.24%-47.69%-41.5%-134.69%15.46%-0.86%36.85%68.23%77.35%41.72%
Net Income (Continuing)43.99M37.74M44.18M57.88M74.73M-162.96M81.02M37.64M117.17M30.25M60.82M91.86M
Discontinued Operations00000001000K01000K00
Minority Interest20.97M330.15M330.59M332.22M326.64M315.74M385.25M319.94M298.65M285.71M282.58M289.92M
EPS (Diluted)0.360.180.230.320.44-0.120.430.600.750.360.380.61
EPS Growth %-18.18%250%-46.51%-46.67%-41.33%-133.33%13.16%-1.64%33.93%20%22.58%41.86%
EPS (Basic)0.360.180.230.320.44-0.120.430.600.750.360.380.61
Diluted Shares Outstanding123.51M123.51M123.51M123.36M126.2M129.18M124.71M123.95M123.86M123.82M123.4M122.63M
Basic Shares Outstanding123.51M123.51M123.51M123.36M128.81M129.18M124.71M123.95M123.86M123.82M123.4M122.63M
Dividend Payout Ratio18.32%38.42%26.88%19.44%14.22%-29.11%20.96%16.56%34.68%33.28%20.35%